Iberdomide (IBER) plus dexamethasone (DEX) in patients with relapsed/refractory multiple myeloma (RRMM): a safety analysis from the CC-220-MM-001 trial

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览10
暂无评分
关键词
relapsed/refractory multiple myeloma,rrmm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要